Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SETD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GAPVD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNPO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDLIM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBFOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED13L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF638-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR3G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOR1AIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC14B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AUNIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on